Guangsheng Zhu

ARID1A, ARID1B, and ARID2 Mutations Serve as Potential Biomarkers for Immune Checkpoint Blockade in Patients With Non-Small Cell Lung Cancer

Guangsheng Zhu, Ruifeng Shi, Zihe Zhang et al. · Frontiers in Immunology · 2021 · 68 citations · Full text

Medicine, Immunology, Oncology +17

Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio Cannot Predict Lymph Node Metastasis and Prognosis in Patients with Early Gastric Cancer: a Single Institution Investigation in China

Guangsheng Zhu, Shaobo Tian, Hui Wang et al. · Current Medical Science · 2018 · 47 citations

Medicine, Oncology, Surgery +14

Systematic pan-cancer analysis showed that RAD51AP1 was associated with immune microenvironment, tumor stemness, and prognosis

Renwang Liu, Guangsheng Zhu, Mingbiao Li et al. · Frontiers in Genetics · 2022 · 43 citations · Full text

Medicine, Cancer Biology, Oncology +17

Neutrophil infiltration associated genes on the prognosis and tumor immune microenvironment of lung adenocarcinoma

Renwang Liu, Guangsheng Zhu, Yonglin Sun et al. · Frontiers in Immunology · 2023 · 34 citations · Full text

Medicine, Immunology, Oncology +17

Identification of small proline‐rich protein <scp>1B</scp> (<scp>SPRR1B</scp>) as a prognostically predictive biomarker for lung adenocarcinoma by integrative bioinformatic analysis

Zihe Zhang, Ruifeng Shi, Songlin Xu et al. · Thoracic Cancer · 2021 · 28 citations · Full text

Medicine, Bioinformatics, Oncology +17